# Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2

> **NCT00691743** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 850 (estimated)

## Conditions studied

- Upper-GI Symptoms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00691743
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2009-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691743, "Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00691743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*